Navigation Links
Data Monitoring Committee Unanimously Recommends Continuation of Celsion's Phase III ThermoDox® HEAT Study to Treat Primary Liver Cancer
Date:9/30/2010

cal resection of the tumor; however 80% to 90% of patients are ineligible for surgery.  Radio frequency ablation (RFA) has increasingly become the standard of care for non-resectable liver tumors, but the treatment becomes less effective for larger tumors. There are few non-surgical therapeutic treatment options available as radiation therapy and chemotherapy are largely ineffective in the treatment of primary liver cancer.

About ThermoDox® and the Phase III HEAT StudyThermoDox® is a proprietary heat-activated liposomal encapsulation of doxorubicin, an approved and frequently used oncology drug for the treatment of a wide range of cancers.  In the HEAT study, ThermoDox is administered intravenously in combination with RFA.  A thermal zone created by the RFA releases the entrapped doxorubicin from the liposome. This delivery technology enables high concentrations of doxorubicin to be deposited preferentially at the targeted tumor.

For primary liver cancer, ThermoDox® is being evaluated in a 600 patient global Phase III study at 75 clinical sites under an FDA Special Protocol Assessment. The study is designed to evaluate the efficacy of ThermoDox in combination with RFA when compared to patients who receive RFA alone as the control. The primary endpoint for the study is progression-free survival (PFS) with a secondary confirmatory endpoint of overall survival.  A pre-planned, interim efficacy analysis will be performed by an independent Data Monitoring Committee when enrollment in the trial is complete and 50 percent of the PFS events are realized in the study population.  Additional information on the Company's ThermoDox® clinical studies may be found at http://www.clinicaltrials.gov.

About CelsionCels
'/>"/>

SOURCE Celsion Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ACC Concerned Over Reporting of Biomonitoring Results
2. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
3. FDA Clears Advanced Test for Monitoring Metastatic Colorectal Cancer
4. Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data
5. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
6. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
7. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
8. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
9. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
10. eRT Announces the Availability of the Suicidality Monitoring System(TM) For Clinical Trials
11. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015   Mallinckrodt Pharmaceuticals (NYSE: MNK ... it has extended the deadline for submitting applications to ... The program awards grants to help fund projects in ... Research Fellowship Awards program is designed to further scientific ... will award a total of 25 positions. The program ...
(Date:5/26/2015)... 2015  Over the past several years, numerous studies ... a sleeve gastrectomy, and weight loss surgery in ... recently, a study conducted by Italian researchers and published ... that obese patients suffering from an overactive bladder tend ... losing weight with a laparoscopic sleeve gastrectomy. This is ...
(Date:5/26/2015)... -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP ) ("the Company"), ... that address unmet medical needs in women,s health, ... will present at the Marcum MicroCap Conference as ... PM EDTLocation: , The Grand Hyatt, New York, ... ,Investor, or  click here The webcast ...
Breaking Medicine Technology:Mallinckrodt Extends Deadline For 2015 Research Fellowship Program 2Mallinckrodt Extends Deadline For 2015 Research Fellowship Program 3Add Overactive Bladder Syndrome to the List of Conditions Shown to Be Improved by a Sleeve Gastrectomy 2Juniper Pharmaceuticals to Present at Investor Conference on May 28, 2015 2
... ROSA, Calif., March 12 Northern California Foot,and ... recruiting patients with,lower extremity diabetic foot ulcers to ... trial will study the effects of Excellarate(TM),(GAM501) (Ad5PDGF-B/bovine ... patients with neuropathic non-healing diabetic foot ulcers. Excellarate,is ...
... with Education & ... ... Journal of,the American Medical Association on the largest weight loss maintenance,study ... both personal contact and web-based support are,identified as the key to ...
Cached Medicine Technology:Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial 2Study Finds Personal and Web-Based Support Equal Weight Loss Success 2Study Finds Personal and Web-Based Support Equal Weight Loss Success 3Study Finds Personal and Web-Based Support Equal Weight Loss Success 4
(Date:5/26/2015)... May 26, 2015 Mr. Gould and Mr. ... will start working together this week to ensure a smooth ... in healthcare executive leadership and strategy. Gary is familiar ... the hiring of Mr. Cochran. The Board of Trustees believe ... the improvement strategies implemented over the past few years. ...
(Date:5/26/2015)... 2015 Neeta Pai was diagnosed with ... fainting spells, four of which landed her in the ... , Though she still struggles with anemia, iron ... her time to increasing HHT awareness and garnering support ... awareness, we could have prevented all the heartbreak and ...
(Date:5/26/2015)... Portland, OR (PRWEB) May 26, 2015 Sexual ... and while Title IX is best known for creating opportunities ... universities accountable for sexual assault response and prevention. In a ... Greene of Global Sports Advocates explains what Title IX ... schools can get in front of this issue to protect ...
(Date:5/26/2015)... 26, 2015 3,000 senior industry executives ... and debate the future of the connected car. A ... steering wheel that can read a driver’s brain waves. ... a driving simulator by mind alone just by gripping ... Logic said: “We are working on cognitive load, altering ...
(Date:5/26/2015)... 2015 Relias Learning , the ... health and human services market, announces expansion of their ... strong attendance and participation in 2014, they will double ... annual user conference an exciting new facelift. , ... together and discuss best practices, share their expertise, provide ...
Breaking Medicine News(10 mins):Health News:Rochester Woman Brings Awareness to Genetic Disease 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 3Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3
... hailed by researchers for its ability to target cancer cells ... ON01910 works by interfering with a molecule known as Plk1, ... This molecule is found in higher numbers in cancerous tumors, ... especially high amounts. ,The drug was tested on ...
... says that mercury pollution in the state of Texas in US ... of autistic children. ,In US, mercury is released in ... to the researchers, on an average, for each 1000 pounds of ... in the rate of autism with 43% increase in the rates ...
... Buffalo University dental researchers have identified some proteins that ... current drugs that are used to treat fungal infections ... anti-fungal properties, even against fungal infections that become resistant ... be increased if they can be protected from the ...
... A recent study says that oil from the fishes contains ... like Mackerel and Salmon, if are taken in a diet ... people with cardiovascular disease and arthritis. In case of absence ... also do the trick. ,Trials have shown previously that ...
... with heart attack calm disease progression but do not help ... be a potential source for regeneration of heart function and ... in this regard. , This has been explained by ... an emerging source for treatment of diseased hearts. However, implanting ...
... a panic disorder may benefit more from treatment combining ... care usually offered by physicians. ,Panic disorder is ... In the study, 232 patients meeting the criteria for ... usual or a treatment combining medication and up to ...
Cached Medicine News:
Taber's Cyclopedic Medical Dictionary has definitions and information they need to provide care for their patients....
Taber's Cyclopedic Medical Dictionary is published by F.A. Davis. Contains approximately 56,000 terms....
Dorland's includes terms of the Terminologia Anatomica on your Palm or Pocket PC PDA or Smartphone....
Stedmans Medical Dictionary is a PDA reference for nursing and allied health professionals and students....
Medicine Products: